5-Hydroxytryptamine receptors in GtoPdb v.2025.3

Ricardo Andrade(Wayne State University), Frank D. Yocca(Bristol-Myers Squibb (United States)), Bryan L. Roth(University of North Carolina at Chapel Hill), Aline Dumuis(Université de Montpellier), Klaus Peter Latté, Trevor Sharp(University of Oxford), Derek N. Middlemiss(GlaxoSmithKline (Netherlands)), Ewan J. Mylecharane(The University of Sydney), Carlos M. Villalón(Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional), Julie G. Hensler(The University of Texas at San Antonio Health Science Center), M. Hamon(Inserm), Andrew J. Sleight(Roche (Sweden)), Luc Maroteaux(Inserm), Joël Bockaert(Wayne State University), Amy Butler(University of Birmingham), René Hen(Columbia University), John A. Peters(University of Dundee), Stephen J. Peroutka, Paul Hartig(DuPont (United States)), Gordon S. Baxter, John F. Neumaier(University of Washington), Daniël Hoyer(Complexity Science Hub), Nicholas M. Barnes(Unknown), Graeme R. Martin, Marlene L. Cohen(Eli Lilly (United States)), Manfred Göthert(University of Bonn), Theresa A. Branchek(Synaptic Research (United States)), P.P.A. Humphrey, Richard M. Eglen(PerkinElmer (United States)), Rebecca Hills(University of Edinburgh), Pramod R. Saxena(Erasmus University Rotterdam), Katharine Herrick‐Davis(Albany Medical Center Hospital)
IUPHAR/BPS Guide to Pharmacology CITE
September 10, 2025
Cited by 1


Related Papers

The promise and peril of chemical probes
|Nature Chemical Biology|2015|848
Neurosteroids and GABAA receptor function
|Trends in Pharmacological Sciences|1995|743
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
|British Journal of Pharmacology|2017|597